查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386203

甲型肝炎疫苗市场报告：2030 年趋势、预测与竞争分析

Hepatitis A Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

甲型肝炎疫苗的趋势和预测

预计到 2030 年，全球甲型肝炎疫苗市场将达到 10 亿美元，2024 年至 2030 年复合年增长率为 3.6%。该市场的主要驱动因素是人们对疫苗接种重要性的认识不断提高、政府遏制甲型肝炎传播的支持措施以及新兴国家医疗基础设施的改善。全球甲型肝炎疫苗市场前景广阔，政府和私人市场都有商机。

甲型肝炎疫苗市场洞察

Lucintel 预测，减毒活病毒疫苗预计将在预测期内出现高速成长，因为它们被广泛用于预防自然感染并建立强大且持久的免疫反应。

在这个市场中，政府机构预计在预测期内将呈现高成长。

由于人口持续增长和甲型肝炎感染数量增加，预计亚太地区在预测期内将经历最高的增长。

市场规模/估计：以金额的甲型肝炎疫苗市场规模估计（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

市场区隔分析：按类型、应用和地区按金额估算的甲型肝炎疫苗市场规模（十亿美元）

区域分析：北美、欧洲、亚太地区和世界其他地区甲型肝炎疫苗市场的区域细分。

成长机会：甲型肝炎疫苗市场按类型、应用和地区进行的成长机会分析。

策略分析：甲肝疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球甲型肝炎疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球甲型肝炎疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 全球甲型肝炎疫苗市场（按类型）
    • 灭活疫苗
    • 减毒活病毒疫苗
  • 全球甲型肝炎疫苗市场按应用
    • 政府机关
    • 私人的
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球甲型肝炎疫苗市场区域分布
  • 北美甲型肝炎疫苗市场
  • 欧洲甲型肝炎疫苗市场
  • 亚太地区甲型肝炎疫苗市场
  • 其他地区甲肝疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球甲型肝炎疫苗市场成长机会（按类型）
    • 全球甲型肝炎疫苗市场成长机会（按应用）
    • 全球甲型肝炎疫苗市场成长机会（按地区）
  • 全球甲型肝炎疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球甲型肝炎疫苗市场产能扩张
    • 全球甲型肝炎疫苗市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • KM Biologics
  • IMBCA
  • ChangSheng
  • Convac
简介目录

Hepatitis A Vaccine Trends and Forecast

The future of the global hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets. The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

A more than 150-page report is developed to help in your business decisions.

Hepatitis A Vaccine by Segment

The study includes a forecast for the global hepatitis A vaccine by type, application, and region.

Hepatitis A Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Inactivated Vaccine
  • Live Attenuated Vaccine

Hepatitis A Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Government Institution
  • Private Sector
  • Others

Hepatitis A Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Hepatitis A Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepatitis A vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepatitis A vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • KM Biologics
  • IMBCA
  • Changsheng
  • Convac

Hepatitis A Vaccine Market Insights

Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Within this market, government institution is expected to witness higher growth over the forecast period.

APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Features of the Global Hepatitis A Vaccine Market

Market Size Estimates: Hepatitis a vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hepatitis a vaccine market size by type, application, and region in terms of value ($B).

Regional Analysis: Hepatitis a vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepatitis A vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepatitis A vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the hepatitis A vaccine market size?

Answer: The global hepatitis A vaccine market is expected to reach an estimated $1.0 billion by 2030.

Q.2 What is the growth forecast for hepatitis A vaccine market?

Answer: The global hepatitis A vaccine market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the hepatitis A vaccine market?

Answer: The major drivers for this market are rising awareness about the importance of immunization, supportive government initiatives to control the spread of hepatitis A, and growing healthcare infrastructure in developing countries.

Q4. What are the major segments for hepatitis A vaccine market?

Answer: The future of the hepatitis A vaccine market looks promising with opportunities in the government institution and private sector markets.

Q5. Who are the key hepatitis A vaccine market companies?

Answer: Some of the key hepatitis A vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Sinovac
  • Zhejiang Pukang
  • Changchun Institute Of Biological
  • KM Biologics
  • IMBCA
  • Changsheng
  • Convac

Q6. Which hepatitis A vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that live attenuated vaccine is expected to witness higher growth over the forecast period due to its widespread usage to prevent natural infection and build a strong and long-lasting immune response.

Q7. In hepatitis A vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to continous growth of population base and rising number of hepatitis A infection affected population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hepatitis A vaccine market by type (inactivated vaccine and live attenuated vaccine), application (government institution, private sector, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Hepatitis A Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Hepatitis A Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Hepatitis A Vaccine Market by Type
    • 3.3.1: Inactivated vaccine
    • 3.3.2: Live Attenuated Vaccine
  • 3.4: Global Hepatitis A Vaccine Market by Application
    • 3.4.1: Government Institution
    • 3.4.2: Private Sector
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Hepatitis A Vaccine Market by Region
  • 4.2: North American Hepatitis A Vaccine Market
    • 4.2.2: North American Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.3: European Hepatitis A Vaccine Market
    • 4.3.1: European Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.3.2: European Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.4: APAC Hepatitis A Vaccine Market
    • 4.4.1: APAC Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.4.2: APAC Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others
  • 4.5: ROW Hepatitis A Vaccine Market
    • 4.5.1: ROW Hepatitis A Vaccine Market by Type: Inactivated vaccine and Live Attenuated Vaccine
    • 4.5.2: ROW Hepatitis A Vaccine Market by Application: Government Institution, Private Sector, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Hepatitis A Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Hepatitis A Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global Hepatitis A Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Hepatitis A Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Hepatitis A Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hepatitis A Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck & Co
  • 7.3: Sanofi
  • 7.4: Sinovac
  • 7.5: Zhejiang Pukang
  • 7.6: Changchun Institute of Biological
  • 7.7: KM Biologics
  • 7.8: IMBCA
  • 7.9: ChangSheng
  • 7.10: Convac